Cita APA (7a ed.)
Zhang, L., Zhang, X., Piao, J., Wang, Z., Tian, H., Liu, Y., & Qu, X. (2026 Supplement 19). Adebrelimab plus apatinib for maintenance treatment of extensive-stage small cell lung cancer after first-line induction with adebrelimab plus chemotherapy (CLOG2402-ADAPT): A multi-center, single-arm, phase II trial. Journal of Clinical Oncology, 44, 271-298.
Cita Chicago Style (17a ed.)
Zhang, Lingyun, Xiuna Zhang, Jinhua Piao, Zhenghua Wang, Hong Tian, Yunpeng Liu, y Xiujuan Qu. "Adebrelimab Plus Apatinib for Maintenance Treatment of Extensive-stage Small Cell Lung Cancer After First-line Induction with Adebrelimab Plus Chemotherapy (CLOG2402-ADAPT): A Multi-center, Single-arm, Phase II Trial." Journal of Clinical Oncology 44 (2026 Supplement 19): 271-298.
Cita MLA (9a ed.)
Zhang, Lingyun, et al. "Adebrelimab Plus Apatinib for Maintenance Treatment of Extensive-stage Small Cell Lung Cancer After First-line Induction with Adebrelimab Plus Chemotherapy (CLOG2402-ADAPT): A Multi-center, Single-arm, Phase II Trial." Journal of Clinical Oncology, vol. 44, 2026 Supplement 19, pp. 271-298.
Precaución: Estas citas no son 100% exactas.